Topics

Assessment of Pupil Light Responses in Patients With Parkinson Disease

2019-10-11 10:03:42 | BioPortfolio

Summary

Parkinson diseases (PD) is the second most common degenerative disease of the central nervous system. The development of early diagnostic biomarkers may help identify at-risk individuals and allow precocious interventions at the onset of disease and more precise monitoring of therapies that may slow disease progression.

Proof of concept studies indicated significant differences in pupil light response between PD patients and healthy controls. The feasibility of using pupillometry for assesment of PD will be examined.

Study Design

Conditions

Parkinson Disease

Intervention

Pupil response to light stimuli

Location

Goldschleger Eye Research Institute, Sheba Medical Center,
Tel HaShomer
Israel
52621

Status

Not yet recruiting

Source

Sheba Medical Center

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-10-11T10:03:42-0400

Clinical Trials [2371 Associated Clinical Trials listed on BioPortfolio]

Color and Pupil Function

This study will examine the effects of different colors of light on pupil function and alertness.

Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients

Voltage fluctuation as a result of brain activity will be recorded into the computer using an EEG device.

Research Study of Treatment for Winter Depression With Different Colors of Light

The specific aim of this study is to test the hypothesis that light stimuli concentrated around 468 nm will evoke a significantly stronger therapeutic response in SAD patients compared to ...

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease

Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well underst...

Superior Colliculus Activity in Parkinson Disease: a Potential Marker?

The ultimate goal of this project is to evaluate a possible new strategy to diagnose earlier Parkinson's disease, using the superior colliculus as a biomarker. Preliminary data from the i...

PubMed Articles [27659 Associated PubMed Articles listed on BioPortfolio]

Colorful glares: Effects of colors on brightness illusions measured with pupillometry.

We hypothesized that pupil constrictions to the glare illusion, where converging luminance gradients subjectively enhance the perception of brightness, would be stronger for 'blue' than for other colo...

CSF and blood biomarkers for Parkinson's disease.

In the management of Parkinson's disease, reliable diagnostic and prognostic biomarkers are urgently needed. The diagnosis of Parkinson's disease mostly relies on clinical symptoms, which hampers the ...

Parkinson's Disease and Light: The Bright and the Dark Sides.

Light exerts a major influence on human behaviour and health, mainly owing to the importance of sight in our lives, but also due to its entrainment of daily rhythms via the suprachiasmatic nucleus, th...

Pupil dilation to emotional expressions in adolescent social anxiety disorder is related to treatment outcome.

Atypical attention to potential social threats, such as emotional faces, may be one of the core mechanisms underlying social anxiety disorder (SAD). Pupil dilation is an index of locus coreuleus-norad...

Nocebo response in Parkinson's disease: A systematic review and meta-analysis.

To estimate the magnitude of the nocebo response in Parkinson's disease and explore possible associations with study characteristics.

Medical and Biotech [MESH] Definitions

Constriction of the pupil in response to light stimulation of the retina. It refers also to any reflex involving the iris, with resultant alteration of the diameter of the pupil. (Cline et al., Dictionary of Visual Science, 4th ed)

A pupillary abnormality characterized by a poor pupillary light reaction, reduced accommodation, iris sector palsies, an enhanced pupillary response to near effort that results in a prolonged, "tonic" constriction, and slow pupillary redilation. This condition is associated with injury to the postganglionic parasympathetic innervation to the pupil. (From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp492-500)

Unequal pupil size, which may represent a benign physiologic variant or a manifestation of disease. Pathologic anisocoria reflects an abnormality in the musculature of the iris (IRIS DISEASES) or in the parasympathetic or sympathetic pathways that innervate the pupil. Physiologic anisocoria refers to an asymmetry of pupil diameter, usually less than 2mm, that is not associated with disease.

A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light (light-near dissociation) and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. (From Adams et al., Principles of Neurology, 6th ed, p279)

Proteins associated with sporadic or familial cases of PARKINSON DISEASE.

More From BioPortfolio on "Assessment of Pupil Light Responses in Patients With Parkinson Disease"

Quick Search

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Searches Linking to this Trial